By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MedsparkMedsparkMedspark
  • Home
  • News & Alerts
    News & AlertsShow More
    Medicare’s AI approval pilot drew warnings before it launched
    By
    msadmin
    September 16, 2026
    GE HealthCare’s new AI tools forecast hospital bottlenecks 72 hours out
    By
    msadmin
    September 16, 2026
    Knowtex bets on evaluation science to sell clinical AI to hospitals
    By
    msadmin
    September 16, 2026
    Pediatric heart models now take seconds instead of a workday
    By
    msadmin
    September 16, 2026
    OpenAI Foundation puts $40M behind cancer vaccine data collection
    By
    msadmin
    September 16, 2026
  • Spotlight
    SpotlightShow More
    Robinhood Ventures Fund II brings retail capital to healthcare AI
    By
    msadmin
    August 13, 2026
    Adialante brings accessible MRI-based cancer screening
    By
    msadmin
    August 11, 2026
    CellType models biology so AI can discover drugs
    By
    msadmin
    August 11, 2026
    Healthcare AI startups in Robinhood Ventures Fund II
    By
    msadmin
    August 11, 2026
    OpenAI launches GPT-Rosalind for life sciences research
    By
    msadmin
    July 17, 2026
  • Articles
    ArticlesShow More
    Proteomics model picks breast cancer drugs from biopsies
    By
    msadmin
    September 10, 2026
    CRISP model reads frozen sections to steer cancer surgery
    By
    msadmin
    September 10, 2026
    Consumer chatbots are building a medical system outside hospitals
    By
    msadmin
    August 21, 2026
    Reasoning gaps hold back AI agents in scientific discovery
    By
    msadmin
    August 11, 2026
    Benchmark scores can’t track real clinical LLM use, Stanford says
    By
    msadmin
    August 11, 2026
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Font ResizerAa
MedsparkMedspark
Font ResizerAa
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
  • Shop
  • Newsletter
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Follow US
Articles

AI Boosts Radiologist Accuracy in Breast Cancer Screening Without Slowing Workflow

A new study shows that AI enhances breast cancer detection by guiding radiologists' attention to suspicious areas, improving accuracy and efficiency.

Yu Chi Huang
By
Yu Chi Huang
Yu Chi Huang
ByYu Chi Huang
Yu Chi is a senior regulatory affairs specialist and medical researcher focusing on medical devices.
Published: July 8, 2025
Share
2 Min Read
SHARE

As first reported by Radiology, AI decision support significantly improves breast cancer detection accuracy among radiologists during screening mammogram reviews. The study, conducted by researchers at Radboud University Medical Center in the Netherlands, evaluated how AI influences not only diagnostic accuracy but also visual search behavior using eye tracking technology.

The researchers equipped 12 radiologists with an eye tracking system as they reviewed mammograms from 150 women—75 with confirmed breast cancer and 75 without. With AI support, radiologists showed improved accuracy without an increase in reading time or reduction in specificity. The eye tracking data further revealed that AI shifted radiologists’ attention toward regions of actual pathology, acting as a visual guide and helping radiologists prioritize their focus.

AI acts as a “second set of eyes”

Jessie J. J. Gommers, M.Sc., joint first author of the study, explained that the AI system effectively nudged radiologists toward potentially malignant areas by marking regions with varying levels of suspicion. A high AI score prompted more careful evaluation, while low scores allowed quicker dismissal of normal cases. This nuanced interaction helped radiologists manage their time and attention more efficiently across cases of varying complexity.

Jessie Gommers. Source: radboudimaging.nl.

While the results are promising, Gommers cautioned against blind reliance on AI outputs. Although current systems perform comparably to radiologists, erroneous suggestions could still lead to missed cancers or unnecessary recalls. To address this, the team is developing tools to assess AI uncertainty and exploring when AI information should be shown during a case review. Gommers emphasized that radiologists must remain accountable and be trained to critically assess AI guidance.

The study underscores AI’s potential to improve both the accuracy and efficiency of breast cancer screening by reshaping how radiologists interact with medical images. By serving as a digital co-pilot rather than a replacement, AI may become an indispensable tool in early cancer detection—if implemented with thoughtful oversight and ongoing education.

VIA:Radiology
Share This Article
Facebook Copy Link Print
Yu Chi Huang
ByYu Chi Huang
Yu Chi is a senior regulatory affairs specialist and medical researcher focusing on medical devices.

You Might Also Like

Articles

Bridging the Gap Between AI Adoption and HIPAA Compliance

By
msadmin
May 6, 2026
Articles

AI in Surgical Research: How Large Language Models Are Accelerating Medical Discovery at the Medical College of Wisconsin

By
msadmin
June 30, 2026
Articles

Embedded transparency is key to equitable AI clinical trials

By
msadmin
July 13, 2026
ArticlesEvents

New Zealand Accelerates Healthcare Innovation With AI and 24/7 Virtual Care Services

By
Yu Chi Huang
July 7, 2025

AI news, analysis, and insights for healthcare, biotech, and pharma.

Facebook Twitter Youtube Linkedin
Quick Links
  • News & Alerts
  • Articles
  • Spotlight
  • Events
About Medspark
  • Mission
  • Services
  • Contact

© Copyright 2026 MedSpark. All rights reserved.

Privacy Policy | Legal